Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
COR Medicine, also known as the COR Clinic of Regenerative Medicine, is a biotechnology and healthcare company based in Beirut, Lebanon, specializing in advanced regenerative therapies. The company focuses on the clinical application of stem cells and secretome-based treatments to address chronic diseases, musculoskeletal injuries, and aesthetic rejuvenation. Led by Dr. Nada Alaaeddine, COR Medicine utilizes proprietary protocols for isolating bioactive molecules and biological activators to stimulate natural tissue repair. Their services range from treating neurodegenerative and autoimmune conditions to providing longevity-focused IV therapies and sexual health support. The clinic integrates scientific research with patient care, maintaining collaborations with academic institutions for clinical studies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on COR Clinic of Regenerative Medicine.